Whitepapers

The growing demand for MDx assays warrants the need for fast and accurate workflows that reduce the cost and time to bring a new assay to market.

A comprehensive qPCR workflow solution that combines all aspects of the qPCR ecosystem, Diomni Enterprise Software links everything together in one unified, powerfully efficient...

Given the vast options for LDT targets, including proteins, RNA, DNA, pathogens, cells, and small molecules, LDT applications are virtually endless.

The molecular diagnostics (MDx) market is estimated to be worth $16.6 billion in 2023, and expected to reach $28.6 billion by 2028, as “Rapid progress in technologies such...

Dr. Diane Kawa from the Cepheid Medical Affairs team will discuss the Xpert® Xpress MVP test that uses clinician-collected and self-collected vaginal swabs (collected in a clinical...

PGx can lead to better overall quality of care by making sure that medications are prescribed with the specific individual in mind rather than guessing what may work best under...

Medical Laboratory Observer recently sat down with Gen Giovannone, Senior Manager of Clinical Chemistry Inside Sales for SEKISUI Diagnostics, to discuss SEKISUI’s initiatives ...

Despite continued struggles with staffing shortages and supply chain issues, clinical laboratory professionals are pushing ahead with greater standardization of processes and ...

Survey results show current usage trends and future challenges for Laboratory Data Analytics

In the age of precision medicine, molecular assays will continue to grow in number and importance. Assay developers face complex challenges as they work to find solutions for ...

Overwhelmed by day-to-day challenges, we all tend to stay too focused on the next test—when we should be considering how to enact changes to truly impact lab workflow, efficiency...

The 2022 Medical Laboratory Observer (MLO) State of the Industry (SOI) survey on molecular diagnostics revealed some intriguing insights on the use of molecular testing by U.S...

COVID-19 is transitioning to an endemic state where testing for this disease must be simplified to catch outbreaks as soon as possible. Organizations can no longer wait for complicated...

Medical Laboratory Observer’s (MLO) third “State of the Industry” survey topic in 2022 is Disease Management. The majority of clinical laboratory professionals responding (93%...